These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 20946188)
1. The use of sirolimus as a rescue therapy in pediatric intestinal transplant recipients. Andres AM; Lopez Santamaría M; Ramos E; Hernandez F; Prieto G; Encinas J; Leal N; Molina M; Sarría J; Tovar J Pediatr Transplant; 2010 Nov; 14(7):931-5. PubMed ID: 20946188 [TBL] [Abstract][Full Text] [Related]
3. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation]. Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812 [TBL] [Abstract][Full Text] [Related]
6. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma. Jiménez-Rivera C; Avitzur Y; Fecteau AH; Jones N; Grant D; Ng VL Pediatr Transplant; 2004 Jun; 8(3):243-8. PubMed ID: 15176961 [TBL] [Abstract][Full Text] [Related]
7. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency. Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147 [TBL] [Abstract][Full Text] [Related]
8. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus. Casas-Melley AT; Falkenstein KP; Flynn LM; Ziegler VL; Dunn SP Pediatr Transplant; 2004 Aug; 8(4):362-6. PubMed ID: 15265163 [TBL] [Abstract][Full Text] [Related]
9. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
10. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF; Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398 [TBL] [Abstract][Full Text] [Related]
11. Sirolimus in pediatric patients: results in the first 6 months post-renal transplant. Hymes LC; Warshaw BL Pediatr Transplant; 2005 Aug; 9(4):520-2. PubMed ID: 16048606 [TBL] [Abstract][Full Text] [Related]
12. Replacing calcineurin inhibitors with mTOR inhibitors in children. Sindhi R; Seward J; Mazariegos G; Soltys K; Seward L; Smith A; Kosmach B; Venkataramanan R Pediatr Transplant; 2005 Jun; 9(3):391-7. PubMed ID: 15910398 [TBL] [Abstract][Full Text] [Related]
13. Indications, tolerance and complications of a sirolimus and calcineurin inhibitor immunosuppression regimen: intermediate experience in pediatric heart transplantation recipients. Matthews K; Gossett J; Kappelle PV; Jellen G; Pahl E Pediatr Transplant; 2010 May; 14(3):402-8. PubMed ID: 20214748 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy and safety of conversion to sirolimus in 85 renal transplant recipients. Sola E; Lopez V; Gutierrez C; Cabello M; Burgos D; Gonzalez Molina M; Hernandez D Transplant Proc; 2009; 41(6):2137-8. PubMed ID: 19715855 [TBL] [Abstract][Full Text] [Related]
15. Early sirolimus therapy in renal transplant recipients at high risk: is it justified? Halim MA; Al-Otaibi T; Johny KV; Hamid MH; Al-Waheeb S; Hasaneen H; Awadain WH; Nawas KM; El-Sayed A; Said T; Nair MP; Nampoory MR Transplant Proc; 2009 Sep; 41(7):2784-8. PubMed ID: 19765435 [TBL] [Abstract][Full Text] [Related]
16. Proteinuria after conversion to sirolimus in renal transplant recipients. Sahin GM; Sahin S; Kantarci G; Ergin H Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308 [TBL] [Abstract][Full Text] [Related]
17. An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency. Peddi VR; Jensik S; Pescovitz M; Pirsch J; Adler SH; Thistlethwaite JR; Vincenti F; Cohen DJ Clin Transplant; 2005 Feb; 19(1):130-6. PubMed ID: 15659146 [TBL] [Abstract][Full Text] [Related]